Cargando…
Acute QT Interval Modifications During Hydroxychloroquine-Azithromycin Treatment in the Context of COVID-19 Infection
Among candidate drugs to treat coronavirus disease 2019 (COVID-19), the combination of hydroxychloroquine (HCQ) and azithromycin (AZ) has received intense worldwide attention. Even as the efficacy of this combination is under evaluation, clinicians have begun to use it largely. As these medications...
Autores principales: | Voisin, Olivier, Lorc’h, Erwan le, Mahé, Annabelle, Azria, Philippe, Borie, Marie-Françoise, Hubert, Sidonie, Ménage, Elodie, Guillerm, Jean-Christophe, Mourad, Jean-Jacques |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mayo Foundation for Medical Education and Research
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7237942/ https://www.ncbi.nlm.nih.gov/pubmed/32753141 http://dx.doi.org/10.1016/j.mayocp.2020.05.005 |
Ejemplares similares
-
QT interval prolongation with hydroxychloroquine plus azithromycin
Publicado: (2020) -
Azithromycin/hydroxychloroquine: Prolongation of the QT interval: case report
Publicado: (2020) -
System biological investigations of hydroxychloroquine and azithromycin targets and their implications in QT interval prolongation
por: Khan, Abdul Arif, et al.
Publicado: (2020) -
THE EFFECT OF TREATMENT WITH HYDROXYCHLOROQUINE AND AZITHROMYCIN ON THE CORRECTED QT INTERVAL IN PATIENTS WITH COVID-19
por: Batemarco, Thomas, et al.
Publicado: (2022) -
Experience With Hydroxychloroquine and Azithromycin in the Coronavirus Disease 2019 Pandemic: Implications for QT Interval Monitoring
por: Ramireddy, Archana, et al.
Publicado: (2020)